The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery

Por Anson, Donald S
Publicado em 2004

Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair

Por Koldej Rachel M, Anson Donald S
Publicado em 2009-10-01

Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair

Por Koldej, Rachel M, Anson, Donald S
Publicado em 2009

Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses

Por Kaidonis, Xenia, Liaw, Wan Chin, Roberts, Ainslie Derrick, Ly, Marleesa, Anson, Donald, Byers, Sharon
Publicado em 2010

Correction of Methylmalonic Aciduria In Vivo Using a Codon-Optimized Lentiviral Vector

Por Wong, Edward S.Y., McIntyre, Chantelle, Peters, Heidi L., Ranieri, Enzo, Anson, Donald S., Fletcher, Janice M.
Publicado em 2014

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA

Por Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Roberts, Ainslie, Clements, Peter R, Dunning, Kylie, Byers, Sharon
Publicado em 2007

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles

Por Anson Donald S, Getty Brian, Dowall Stuart D, Dennis Mike J, Sharpe Sally A, Bridge Simon H, Skinner Michael A, Stewart James P, Blanchard Tom J
Publicado em 2011-09-01

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles

Por Bridge, Simon H, Sharpe, Sally A, Dennis, Mike J, Dowall, Stuart D, Getty, Brian, Anson, Donald S, Skinner, Michael A, Stewart, James P, Blanchard, Tom J
Publicado em 2011